Meet Us at the 29th Annual Meeting of Japan Society of Gene and Cell Therapy, 11–13 September 2023, Osaka, Japan

MDPI will attend the 29th Annual Meeting of Japan Society of Gene and Cell Therapy. This event will be held at the Osaka International Convention Center for three days from Monday, 11 September, to Wednesday, 13 September 2023.

The theme of this meeting is “Gene Therapy Making a Leap Forward – A Bridge to the Future through Cooperation between Industry, Government and Academia”. Gene and cell therapy has so far been centered on blood diseases, cancers, and metabolic disorders, but gene therapy for spinal muscular atrophy, an intractable neurological disease, was also launched in the US and Japan. Regulations must be well discussed with government agencies, PMDA, and other agencies. The Society will develop a meaningful program to enable sufficient discussions between stakeholders. In addition, a session will be organized by the Scientific Program Committee, a new committee established by the Japan Society of Gene and Cell Therapy.

The following MDPI journals will be represented:

IJMS;
CIMB;
Antioxidants;
Cancers;
Current Oncology;
Metabolites;
SynBio;
Biologics;
Genes;
Hemato.

If you plan on attending this conference, please feel free to stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.c-linkage.co.jp/jsgct2023/en/index_en.html.